Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in ...

Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment ...

A Nigerian-born researcher and doctoral student at the University of Nebraska Medical Center (UNMC), Ayomide Akomolafe has ...

Daraxonrasib improved survival in metastatic pancreatic cancer in Phase III, signaling meaningful progress for therapies targeting RAS‑driven disease.

A team of University of Alberta researchers has developed a cardio-oncology drug that protects the heart from chemotherapy ...

Researchers at Ben-Gurion University of the Negev have identified a protein that plays a central role in enabling aggressive ...

Innate immunity is a cornerstone of the body’s immediate defense against cancer, orchestrating the early recognition and response to tumor cells through key ...

Nutritionists Link Everyday Food Preservatives to Higher Cancer and Type 2 Diabetes Risk ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers. The project, "A novel ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Co-primary efficacy in RAS G12–mutant PDAC included statistically significant OS and PFS gains assessed by blinded ...